Digital The politics of global AI: US tech leaders must listen to th... Reliance on US big tech is now being challenged around the world at a time when geopolitical instability is eroding global trust in US leadership.
News Entropy, UCSF Pre-CTA for Ph2 psilocin vs Lexapro in MDD Entropy signs Pre-CTA with UCSF to develop a US-based Phase 2 trial comparing IV psilocin treatment directly against escitalopram (Lexapro) in MDD.
R&D Understanding Operation Trialblazer, with Dr Harpreet Singh Dr Harpreet Singh, CMO at Precision for Medicine, brings both an insider and outsider perspective to discussing Operation TRIALBLAZER.
News OpenAI Foundation pledges $100m to boost hepatitis C cure ra... The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
News FDA issues summary of grants, promotes rare disease research The US Food and Drug Administration (FDA) has provided an ‘at-a-glance’ summary of the agency’s news.
News RNAi biotech City hauls in $200m in upsized IPO City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.